285 related articles for article (PubMed ID: 27385316)
1. Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: A retrospective study.
Gong C; Yang B; Shi Y; Liu Z; Wan L; Zhang H; Jiang D; Zhang L
Int J Hyperthermia; 2016 Aug; 32(5):496-503. PubMed ID: 27385316
[TBL] [Abstract][Full Text] [Related]
2. High intensity focused ultrasound treatment of adenomyosis: The relationship between the features of magnetic resonance imaging on T2 weighted images and the therapeutic efficacy.
Gong C; Setzen R; Liu Z; Liu Y; Xie B; Aili A; Zhang L
Eur J Radiol; 2017 Apr; 89():117-122. PubMed ID: 28267526
[TBL] [Abstract][Full Text] [Related]
3. High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility.
Zhang L; Rao F; Setzen R
Acta Obstet Gynecol Scand; 2017 Jun; 96(6):707-714. PubMed ID: 28437003
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting effects of ultrasound guided high intensity focused ultrasound for single uterine fibroids: a retrospective analysis.
Fan HJ; Cun JP; Zhao W; Huang JQ; Yi GF; Yao RH; Gao BL; Li XH
Int J Hyperthermia; 2018; 35(1):534-540. PubMed ID: 30428735
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing USgHIFU ablation for adenomyosis with NPVR ≥ 50.
Yu JW; Yang MJ; Jiang L; Su XY; Chen JY
Int J Hyperthermia; 2023; 40(1):2211753. PubMed ID: 37211351
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the dosimetry for high-intensity focused ultrasound ablation of uterine fibroids: a retrospective study.
Peng S; Zhang L; Hu L; Chen J; Ju J; Wang X; Zhang R; Wang Z; Chen W
Medicine (Baltimore); 2015 Apr; 94(13):e650. PubMed ID: 25837756
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of high intensity focused ultrasound treatment for different types of adenomyosis based on magnetic resonance imaging classification.
Gong C; Wang Y; Lv F; Zhang L; Wang Z
Int J Hyperthermia; 2022; 39(1):530-538. PubMed ID: 35300545
[TBL] [Abstract][Full Text] [Related]
8. Effects of oxytocin on high intensity focused ultrasound (HIFU) ablation of adenomysis: a prospective study.
Zhang X; Zou M; Zhang C; He J; Mao S; Wu Q; He M; Wang J; Zhang R; Zhang L
Eur J Radiol; 2014 Sep; 83(9):1607-11. PubMed ID: 24951357
[TBL] [Abstract][Full Text] [Related]
9. Comparison efficacy of ultrasound-guided HIFU for adenomyosis-associated dysmenorrhea with different signal intensity on T2-weighted MR imaging.
Yu J; Jiang L; Su X; Yang M; Yang C; Chen J
J Obstet Gynaecol Res; 2023 Apr; 49(4):1189-1197. PubMed ID: 36733261
[TBL] [Abstract][Full Text] [Related]
10. Effective ablation therapy of adenomyosis with ultrasound-guided high-intensity focused ultrasound.
Zhang X; Li K; Xie B; He M; He J; Zhang L
Int J Gynaecol Obstet; 2014 Mar; 124(3):207-11. PubMed ID: 24380611
[TBL] [Abstract][Full Text] [Related]
11. Safety of ultrasound-guided high-intensity focused ultrasound ablation for diffuse adenomyosis: A retrospective cohort study.
Feng Y; Hu L; Chen W; Zhang R; Wang X; Chen J
Ultrason Sonochem; 2017 May; 36():139-145. PubMed ID: 28069193
[TBL] [Abstract][Full Text] [Related]
12. Non-contrast enhanced MRI for efficiency evaluation of high-intensity focused ultrasound in adenomyosis ablation.
Si M; Lv F; Tang M; Liu Y; Qiu X; Gong C; Hu Y; Liu Y
Int J Hyperthermia; 2024; 41(1):2295813. PubMed ID: 38234000
[TBL] [Abstract][Full Text] [Related]
13. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid.
Lee JS; Hong GY; Lee KH; Kim TE
BJOG; 2017 Aug; 124 Suppl 3():18-22. PubMed ID: 28856867
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pregnancy outcomes in infertile patients with different types of adenomyosis treated with high-intensity focused ultrasound.
Wei J; Wang L; Tao H; Wang X; Zheng F; He P; Zhou L; Fan L; Chen J; Zhong H; Huang W; Zeng D; Li J
Int J Hyperthermia; 2023; 40(1):2238140. PubMed ID: 37495217
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging.
Zhao WP; Chen JY; Zhang L; Li Q; Qin J; Peng S; Li KQ; Wang ZB; Chen WZ
Eur J Radiol; 2013 Jan; 82(1):e43-9. PubMed ID: 23000188
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis.
Keserci B; Duc NM
Int J Hyperthermia; 2018; 35(1):626-636. PubMed ID: 30307340
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging T2WI hyperintense foci number and the prognosis of adenomyosis after high-intensity focused ultrasound treatment.
Du CC; Wang YQ; Qu DC; Jiang LP; Yu X; Zhou HG
Int J Gynaecol Obstet; 2021 Aug; 154(2):241-247. PubMed ID: 33421123
[TBL] [Abstract][Full Text] [Related]
18. [Pregnancy outcomes and symptom improvement of patients with adenomyosis treated with high intensity focused ultrasound ablation].
Zhou CY; Xu XJ; He J
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):845-849. PubMed ID: 27916069
[No Abstract] [Full Text] [Related]
19. Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: A retrospective study.
Xiong Y; Yue Y; Shui L; Orsi F; He J; Zhang L
Int J Hyperthermia; 2015; 31(7):777-83. PubMed ID: 26367457
[TBL] [Abstract][Full Text] [Related]
20. The role of T1 perfusion-based classification in predicting the outcome of magnetic resonance-guided high-intensity focused ultrasound treatment of adenomyosis.
Keserci B; Duc NM
Int J Hyperthermia; 2018 May; 34(3):306-314. PubMed ID: 28540825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
